Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials
Ghent University Hospital · Gene Therapy Laboratory · +8 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
679
total citations
- FWCI
- 67.88
- Percentile
- 100%
- References
- 45
Citations per year
Authors
14- PGPhilippe Gevaert
Ghent University Hospital
- TATheodore A. OmachiCorresponding
Gene Therapy Laboratory
- JCJonathan Corren
University of California, Los Angeles
- JMJoaquim Mullol
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona
- JKJoseph K. Han
Eastern Virginia Medical School
Topics & keywords
Topics
Keywords
- Nasal polyps
- Medicine
- Omalizumab
- Nasal congestion
- Placebo
- Nose
- Internal medicine
- Asthma
No related works found for this paper.